Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone (Q42971327)
scientific article published on 13 July 2010
Language:
(P31) (Q13442814)
(P50) (Q26338766)
(Q57233657)
(Q87013105)
(Q87712102)
(Q92468485)
(Q3167165)
(Q91110230)
(Q114442095)
(Q89582275)
(Q114442105)
(Q114442097)
(P304) 3743-3750
(P407) (Q1860)
(P433) 19
(P478) 116
(P577) Tuesday, July 13, 2010
(P921) (Q467635)
(P1433) (Q885070)
(P1476) "Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone" (language: en)
(P2093) Rudolf Schlag
Ofer Shpilberg
Martin Kropff
Alain Kentos
Anatoly Golenkov
Kevin Liu
Jesús F San Miguel
other details
description scientific article published on 13 July 2010

External Links